Inmedix Raises $250,000 Over 10 Years for Pediatric Rheumatology

NORMANDY PARK, WA, UNITED STATES, October 5, 2026 /CourierPR/ -- Inmedix, Inc., a Seattle-based biotech/medtech company, has raised $250,000 over the past decade to support the Pediatric Rheumatology Division at Seattle Children’s Hospital. This significant sum was achieved through its 10th annual charity golf tournament, which added $43,695.44 to the total. The event, held at the Club at Snoqualmie Ridge on Monday, August 31, 2026, saw all collected fees donated entirely to support children with autoimmune joint diseases.

Since receiving FDA clearance for its CloudHRV® diagnostic system in January 2025, Inmedix has been at the forefront of advancing heart rate variability (HRV) assessment. CloudHRV is the first system cleared by the FDA as a cloud-based, heart rate variability diagnostic calculated from a high-fidelity 5-minute electrocardiogram (ECG), which also includes Baevsky indices of parasympathetic and sympathetic activity. This milestone represents a significant step in modern HRV assessment, offering precision, scalability, and affordability for both patients and their caregivers in clinical settings.

Inmedix’s commitment to supporting children with autoimmune diseases began eight years before the company’s commercial launch of CloudHRV. Dr. Andrew J. Holman, the company’s CEO and co-founder, led the initiative to support Seattle Children’s Hospital through the annual charity golf tournament.

The 10th annual Inmedix charity golf tournament was a significant event in the company’s history. It not only raised funds but also highlighted the company’s dedication to supporting children with autoimmune joint diseases. The comprehensive bill from the event was given to the sole sponsor, Inmedix Inc., to ensure that all collected fees went 100% to support kids with arthritis.

The company’s support has been crucial for the Pediatric Rheumatology Division at Seattle Children’s. The funds have been used to support research and other pressing needs within the division, helping to improve the lives of children with autoimmune joint diseases. The 11th annual Inmedix Charity Golf event is planned for late August 2027. The company extends its gratitude to all the patrons who have participated year after year, as well as to the Club at Snoqualmie Ridge, its catering, groundskeepers, and pro shop staff, and to the folks at BackSwing Golf Events for their continued support in making these annual events successful.

Inmedix’s commitment to supporting children with autoimmune diseases through the charity golf tournament has been a cornerstone of the company’s corporate social responsibility. The event has not only raised funds but also brought together a community of supporters, sponsors, and participants who share a common goal of helping children with autoimmune joint diseases. The success of the 10th annual event underscores the importance of such initiatives in supporting pediatric healthcare and research.